Skip to main content

Table 1 Outcome measures

From: Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trial

Primary objectives outcome measures Secondary objectives outcome measures
  Pain and function outcomes Menopause symptoms Joint appearance
• Rates of eligible participant identification (screening period)
• Rates of recruitment/randomisation from different sources (screening period)
• Retention rates (throughout study)
• Study medication compliance a
• Bang’s Blinding Index (likelihood of unblinding) [40] a
• Average hand pain (rated over 14 days preceding the study visit)c a
• Pain manikin–capturing pain in other joints in the 4 weeks preceding the study visita
• Functional Index for Hand OsteoArthritis (FIHOA) questionnaire [41, 42]b
• Grip strength, by Jamar dynamometer [43]b
• EQ-5D-5L questionnaire [44, 45]b
• Menopause-specific Quality of Life (MENQOL) questionnaire (Intervention 1-month recall version) [38, 46, 47]b
• Greene Climacteric Scale [48]b
• Cosmesis score (single question, Michigan Hand Questionnaire) [49]b
• Investigator-recorded tender and swollen joint counts a
• Photographic recording of swollen hand joints a
  1. aSee Fig. 1 for collection time points
  2. bSee “Questionnaires” in Table 2 for collection time points
  3. cProposed primary outcome for full trial